Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial.

Brown MT, Murphy FT, Radin DM, Davignon I, Smith MD, West CR.

Arthritis Rheum. 2013 Jul;65(7):1795-803. doi: 10.1002/art.37950.

2.

Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial.

Brown MT, Murphy FT, Radin DM, Davignon I, Smith MD, West CR.

J Pain. 2012 Aug;13(8):790-8. doi: 10.1016/j.jpain.2012.05.006. Epub 2012 Jul 10.

PMID:
22784777
3.

A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee.

Spierings EL, Fidelholtz J, Wolfram G, Smith MD, Brown MT, West CR.

Pain. 2013 Sep;154(9):1603-12. doi: 10.1016/j.pain.2013.04.035. Epub 2013 Apr 22.

PMID:
23707270
4.

Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.

Schnitzer TJ, Ekman EF, Spierings EL, Greenberg HS, Smith MD, Brown MT, West CR, Verburg KM.

Ann Rheum Dis. 2015 Jun;74(6):1202-11. doi: 10.1136/annrheumdis-2013-204905. Epub 2014 Mar 13.

PMID:
24625625
5.

Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

Balanescu AR, Feist E, Wolfram G, Davignon I, Smith MD, Brown MT, West CR.

Ann Rheum Dis. 2014 Sep;73(9):1665-72. doi: 10.1136/annrheumdis-2012-203164. Epub 2013 Jul 12.

PMID:
23852695
6.

Efficacy and safety of intravenous tanezumab for the symptomatic treatment of osteoarthritis: 2 randomized controlled trials versus naproxen.

Ekman EF, Gimbel JS, Bello AE, Smith MD, Keller DS, Annis KM, Brown MT, West CR, Verburg KM.

J Rheumatol. 2014 Nov;41(11):2249-59. doi: 10.3899/jrheum.131294. Epub 2014 Oct 1.

PMID:
25274899
8.

Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain.

Kivitz AJ, Gimbel JS, Bramson C, Nemeth MA, Keller DS, Brown MT, West CR, Verburg KM.

Pain. 2013 Jul;154(7):1009-21. doi: 10.1016/j.pain.2013.03.006. Epub 2013 Mar 14.

PMID:
23628600
9.

Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial.

DeLemos BP, Xiang J, Benson C, Gana TJ, Pascual ML, Rosanna R, Fleming B.

Am J Ther. 2011 May;18(3):216-26. doi: 10.1097/MJT.0b013e3181cec307.

PMID:
20215961
10.

Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial.

Lambert RG, Hutchings EJ, Grace MG, Jhangri GS, Conner-Spady B, Maksymowych WP.

Arthritis Rheum. 2007 Jul;56(7):2278-87.

11.

Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study.

Nagashima H, Suzuki M, Araki S, Yamabe T, Muto C; Tanezumab Investigators.

Osteoarthritis Cartilage. 2011 Dec;19(12):1405-12. doi: 10.1016/j.joca.2011.09.006. Epub 2011 Oct 5.

12.

Efficacy and safety of E-OA-07 in moderate to severe symptoms of osteoarthritis: a double-blind randomized placebo-controlled study.

Kulkarni MP, Shakeel A, Shinde BS, Rosenbloom RA.

Am J Ther. 2011 Mar-Apr;18(2):170-7. doi: 10.1097/MJT.0b013e318209df49.

PMID:
21317618
13.

A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis.

Kotevoglu N, Iyibozkurt PC, Hiz O, Toktas H, Kuran B.

Rheumatol Int. 2006 Feb;26(4):325-30. Epub 2005 Jun 15.

PMID:
15959784
14.

A randomized, double-blind, placebo-controlled 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis.

Prior MJ, Harrison DD, Frustaci ME.

Curr Med Res Opin. 2014 Nov;30(11):2377-87. doi: 10.1185/03007995.2014.949646. Epub 2014 Aug 14.

PMID:
25121804
15.

Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group.

Altman RD, Moskowitz R.

J Rheumatol. 1998 Nov;25(11):2203-12. Erratum in: J Rheumatol 1999 May;26(5):1216.

PMID:
9818665
19.

Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee.

Tiseo PJ, Kivitz AJ, Ervin JE, Ren H, Mellis SJ.

Pain. 2014 Jul;155(7):1245-52. doi: 10.1016/j.pain.2014.03.018. Epub 2014 Mar 29.

PMID:
24686255
20.

Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial.

Gana TJ, Pascual ML, Fleming RR, Schein JR, Janagap CC, Xiang J, Vorsanger GJ; 023 Study Group.

Curr Med Res Opin. 2006 Jul;22(7):1391-401.

PMID:
16834838

Supplemental Content

Support Center